CIK 0001232524
- Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- EIN
- 981032470
- Phone
- +353 16347800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-05 | Tovey Christopher J. EVP COO & Managing Dir EUR/INT | Grant or award | +9,091 | 9,116 | ||
| 2021-05-05 | COZADD BRUCE C Chairman & CEO | Sale | −500 | $170.00 | $85K | 321,341 |
| 2021-05-03 | COZADD BRUCE C Chairman & CEO | Sale | −1,500 | $164.24 | $246K | 321,841 |
| 2021-04-05 | GALA RENEE D EVP & CFO | Shares withheld for taxes | −1,515 | $164.71 | $250K | 25,347 |
| 2021-04-01 | COZADD BRUCE C Chairman & CEO | Sale | −1,500 | $164.96 | $247K | 323,341 |
| 2021-03-09 | Carr Patricia VP, Finance & PAO | Sale | −961 | $161.50 | $155K | 6,045 |
| 2021-03-08 | Larkin Finbar SVP, Technical Operations | Sale | −1,509 | $161.60 | $244K | 16,519 |
| 2021-03-08 | Carr Patricia VP, Finance & PAO | Sale | −1,089 | $161.61 | $176K | 7,006 |
| 2021-03-05 | Swisher Daniel N JR President and COO | Shares withheld for taxes | −3,718 | $164.75 | $613K | 49,961 |
| 2021-03-05 | Pearce Samantha SVP, Head of Europe & Intl | Shares withheld for taxes | −1,402 | $164.75 | $231K | 11,958 |
| 2021-03-05 | Patil Neena M SVP, General Counsel | Shares withheld for taxes | −691 | $164.75 | $114K | 26,147 |
| 2021-03-05 | Iannone Robert EVP R&D, Chief Medical Officer | Shares withheld for taxes | −741 | $164.75 | $122K | 30,145 |
| 2021-03-05 | COZADD BRUCE C Chairman & CEO | Shares withheld for taxes | −21,516 | $164.75 | $3.5M | 324,841 |
| 2021-03-01 | COZADD BRUCE C Chairman & CEO | Sale | −9,600 | $170.00 | $1.6M | 346,357 |
| 2021-02-25 | Swisher Daniel N JR President and COO | Grant or award | +11,695 | 53,679 | ||
| 2021-02-25 | Sablich Kim EVP & GM, North America | Grant or award | +8,535 | 25,335 | ||
| 2021-02-25 | Pearce Samantha SVP, Head of Europe & Intl | Grant or award | +3,160 | 13,360 | ||
| 2021-02-25 | Patil Neena M Chief Legal Officer (CLO) and | Grant or award | +7,270 | 26,838 | ||
| 2021-02-25 | Larkin Finbar SVP, Technical Operations | Grant or award | +3,950 | 18,028 | ||
| 2021-02-25 | Iannone Robert EVP, Research & Development | Grant or award | +8,535 | 30,886 |
Page 33 of 39 · 780 trades